This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Khan, F. Articles by Belch, J. J. Search for Related Content PubMed PubMed Citation Articles by Khan, F. Articles by Belch, J. J. Social Bookmarking                         What's this?

Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease

University Department of Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK

Stuart J Litchfield

University Department of Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK

Peter A Stonebridge

University Department of Surgery, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK

Jill JF Belch

University Department of Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK

Elevated blood cholesterol is a major risk factor for atherosclerosis. Recent studies show that lowering cholesterol reduces the risk of vascular disease, but the precise mechanisms for vascular improvement are not fully understood. Furthermore, it is not known whether the beneficial effects of cholesterol lowering extend to the skin microvasculature. In this unrandomized, open design study, we used iontophoresis and laser Doppler flowmetry to examine forearm skin perfusion in hypercholesterolaemic patients with PAOD before and after cholesterol-lowering therapy with fluvastatin.

Endothelium-dependent and -independent vasodilatation were measured following skin iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP), respectively.

Before cholesterol-lowering, vascular responses to ACh and SNP were reduced significantly in patients compared with responses in control subjects (p, 0.001 and p, 0.05, ANOVA, respectively). Fluvastatin therapy (40 mg/day) for 24 weeks significantly reduced total cholesterol (7.3 6 0.3 to 6.0 6 0.2 mmol/l, p, 0.001) and LDL cholesterol (5.4 6 0.5 to 4.2 6 0.4 mmol/l, p, 0.01). Vasodilatation to SNP was significantly improved at week 24 (p, 0.05).

In patients with hypercholesterolaemia and PAOD, cholesterol-lowering with statin therapy significantly improved endothelium-independent vascular responses to SNP in skin microvessels. The application of the non-invasive techniques of iontophoresis and laser Doppler flowmetry may provide useful markers for the assessment of microvascular function in this group of patients.

Key Words: endothelium • hypercholesterolaemia • iontophoresis • peripheral arterial obstructive disease • skin • vasodilatation

Vascular Medicine, Vol. 4, No. 4, 233-238 (1999)
DOI: 10.1177/1358836X9900400405


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K de Leeuw, J Blaauw, A. Smit, C. Kallenberg, and M Bijl Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired Lupus, November 1, 2008; 17(11): 1010 - 1017. [Abstract] [PDF]

				M. A. Black, D. J. Green, and N. T. Cable Exercise prevents age-related decline in nitric-oxide-mediated vasodilator function in cutaneous microvessels J. Physiol., July 15, 2008; 586(14): 3511 - 3524. [Abstract] [Full Text] [PDF]

				L. A. Holowatz, C. S. Thompson-Torgerson, and W. L. Kenney The human cutaneous circulation as a model of generalized microvascular function J Appl Physiol, July 1, 2008; 105(1): 370 - 372. [Full Text] [PDF]

				C.-H. Lee, H.-R. Chang, J.-S. Chen, G.-S. Chen, and H.-S. Yu Defective Adrenergic Responses in Patients With Arsenic-induced Peripheral Vascular Disease Angiology, April 1, 2007; 58(2): 161 - 168. [Abstract] [PDF]

				T. W. Rice and A. B. Lumsden Optimal Medical Management of Peripheral Arterial Disease Vascular and Endovascular Surgery, August 1, 2006; 40(4): 312 - 327. [Abstract] [PDF]

				J. M.R. Gill, A. Al-Mamari, W. R. Ferrell, S. J. Cleland, C. J. Packard, N. Sattar, J. R. Petrie, and M. J. Caslake Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2375 - 2382. [Abstract] [Full Text] [PDF]

				F. Khan, K. Elherik, C. Bolton-Smith, R. Barr, A. Hill, I. Murrie, and J. J.F Belch The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects Cardiovasc Res, October 1, 2003; 59(4): 955 - 962. [Abstract] [Full Text] [PDF]

				J. M McKenney Potential Nontraditional Applications of Statins Ann. Pharmacother., July 1, 2003; 37(7): 1063 - 1071. [Abstract] [Full Text] [PDF]

				F. Khan and D. J. Newton Laser Doppler Imaging in the Investigation of Lower Limb Wounds International Journal of Lower Extremity Wounds, June 1, 2003; 2(2): 74 - 86. [Abstract] [PDF]

				A. T Hirsch and A. M Gotto Jr Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction Vascular Medicine, November 1, 2002; 7(4): 323 - 331. [Abstract] [PDF]

				J. E. Ramsay, W. R. Ferrell, L. Crawford, A. M. Wallace, I. A. Greer, and N. Sattar Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4231 - 4237. [Abstract] [Full Text] [PDF]